Nauck, M. A., McGuire, D. K., Pieper, K. S., Lokhnygina, Y., Strandberg, T. E., Riefflin, A., . . . Holman, R. R. (2019). Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: Observations from TECOS. Cardiovasc Diabetol.
Citação norma ChicagoNauck, Michael A., et al. "Sitagliptin Does Not Reduce the Risk of Cardiovascular Death or Hospitalization for Heart Failure Following Myocardial Infarction in Patients With Diabetes: Observations From TECOS." Cardiovasc Diabetol 2019.
MLA CitationNauck, Michael A., et al. "Sitagliptin Does Not Reduce the Risk of Cardiovascular Death or Hospitalization for Heart Failure Following Myocardial Infarction in Patients With Diabetes: Observations From TECOS." Cardiovasc Diabetol 2019.